What is STAT-ON? STAT-ON is a wearable medical device designed for the continuous and objective monitoring of motor symptoms in patients with Parkinson’s disease during their daily daily activities [1]. The system is based on an advanced inertial sensing system and previously trained artificial intelligence algorithms capable of automatically detecting and quantifying relevant motor symptoms […]
- agosto 2026
-
-
MoMoPa–AM: Monitoring of Mobility in People with Parkinson’s Disease through Multimodal Analysis MoMoPa–AM: Monitoring of Mobility in People with Parkinson’s Disease through Multimodal Analysis Over the past two years, our team at Sense4Care has been working to push the boundaries of quantitative motor assessment in Parkinson’s disease. Within the MoMoPa–AM project, Sense4Care, together with our […]
-
STAT-ON® in Real-World Clinical Practice: Insights from the MoMoPa-EC Trial 1. Introduction Parkinson’s disease (PD) is a complex and fluctuating condition. Patients experience alternating periods of good motor function (“ON” time) and impaired mobility (“OFF” time). Monitoring these fluctuations is critical for optimizing treatment, yet traditional approaches rely heavily on subjective patient reporting. Wearable medical […]
-
Sense4Care, in collaboration with the Research Area of CSAPG, has obtained funding to lead the new MoMoPa-AM project. This project, prominently driven by Sense4Care’s commitment to advancing healthcare technology, focuses on enhancing mobility monitoring in patients with Parkinson’s disease. This significant venture is a continuation of the MoMoPa series of studies on Parkinson’s disease, initiated […]
-
We are glad to announce our partnership agreement with EVER Pharma to introduce the medical device STAT-ON in Germany. With this agreement, Sense4Care aims to reinforce the adaption of STAT-ON in Europe, and being now present in 14 countries worldwide.
-
We present our latest journal article about 𝐒𝐓𝐀𝐓-𝐎𝐍 at 𝐅𝐫𝐨𝐧𝐭𝐢𝐞𝐫𝐬 𝐢𝐧 𝐍𝐞𝐮𝐫𝐨𝐥𝐨𝐠𝐲. The work done so far about STAT-ON, including projects, clinical studies, algorithms, and current clinical validation since 2009 is included. A fantastic compendium of information going through the REMPARK project to the SME Instrument Phase II PARK-IT2 project.This is a powerful journal paper […]
-
Evidence to STAT-ON as a Solution for Early Detection and Awareness of Movement Fluctuations in Parkinson’s Disease In this 2020 edition of the International Congress of Parkinson’s Disease and Movement Disorders (MDS Congress), that took place for first time in virtual format due to the current situation generated by the COVID-19 pandemic, two posters has […]
-
We are glad to announce our partnership agreement with EVER Pharma (UK) for STAT-ON usage within the UK! We are excited for all the great upcoming projects!
- Load more...